30 Day Trial

Xtant Medical Posts 20.5% Orthobiologics Growth in 2Q17


Xtant Medical posted 2Q17 revenue of US $21.4MM, -0.3% vs. 2Q16, with 1H17 revenue of $43.5MM, +2.5% vs. 1H16.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.